Skip to main content
Top
Literature
1.
2.
go back to reference CostedoatChalumeau N, Hulot JS, Amoura Z, Delcourt A, Maisonobe T, Dorent R, Bonnet N, Sable R, Lechat P, Wechsler B, Piette JC (2007) Cardiomyopathy related to antimalarial therapy. Cardiology. 107:73–80CrossRef CostedoatChalumeau N, Hulot JS, Amoura Z, Delcourt A, Maisonobe T, Dorent R, Bonnet N, Sable R, Lechat P, Wechsler B, Piette JC (2007) Cardiomyopathy related to antimalarial therapy. Cardiology. 107:73–80CrossRef
3.
go back to reference Soong TR, Barouch LA, Champion HC et al (2007) New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy—a report of 2 cases. Hum Pathol 38:1858–1863CrossRefPubMed Soong TR, Barouch LA, Champion HC et al (2007) New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy—a report of 2 cases. Hum Pathol 38:1858–1863CrossRefPubMed
4.
5.
go back to reference Joyce E, Fabre A, Mahon N (2013) Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. Eur Heart J Acute Cardiovasc Care 2:77–83CrossRefPubMedPubMedCentral Joyce E, Fabre A, Mahon N (2013) Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. Eur Heart J Acute Cardiovasc Care 2:77–83CrossRefPubMedPubMedCentral
6.
go back to reference Tönnesmann E, Kandolf R, Lewalter T (2012) Chloroquine cardiomyopathy-a review of the literature. Immunopharmacol Immunotoxicol 35:434–442CrossRef Tönnesmann E, Kandolf R, Lewalter T (2012) Chloroquine cardiomyopathy-a review of the literature. Immunopharmacol Immunotoxicol 35:434–442CrossRef
7.
go back to reference Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY (2014) Hydroxychloroquineinduced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol 30:1706–1715CrossRefPubMed Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY (2014) Hydroxychloroquineinduced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol 30:1706–1715CrossRefPubMed
8.
go back to reference Sumpter MD, Tatro LS, Stoecker WV, Rader RK (2012) Evidence for risk of cardiomyopathy with hydroxychloroquine. Lupus 21:1594–1596CrossRefPubMed Sumpter MD, Tatro LS, Stoecker WV, Rader RK (2012) Evidence for risk of cardiomyopathy with hydroxychloroquine. Lupus 21:1594–1596CrossRefPubMed
9.
go back to reference Muthukrishnan P, Roukoz H, Grafton G (2011) Hydroxychloroquine-induced cardiomyopathy: a case report. Circ Heart Fail. 4:e7–e8CrossRefPubMed Muthukrishnan P, Roukoz H, Grafton G (2011) Hydroxychloroquine-induced cardiomyopathy: a case report. Circ Heart Fail. 4:e7–e8CrossRefPubMed
Metadata
Title
Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis
Authors
Amr Abdin
Janine Pöss
Reinhard Kandolf
Holger Thiele
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology / Issue 3/2017
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1064-z

Other articles of this Issue 3/2017

Clinical Research in Cardiology 3/2017 Go to the issue